Ontario Teachers Pension Plan Board lifted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 6.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,173,535 shares of the insurance provider's stock after acquiring an additional 71,910 shares during the period. Humana accounts for approximately 3.2% of Ontario Teachers Pension Plan Board's portfolio, making the stock its 14th biggest holding. Ontario Teachers Pension Plan Board owned 0.97% of Humana worth $371,705,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Pzena Investment Management LLC boosted its stake in Humana by 538.7% in the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock worth $866,250,000 after buying an additional 1,955,375 shares during the last quarter. Marshall Wace LLP boosted its position in shares of Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock worth $532,564,000 after acquiring an additional 774,085 shares during the last quarter. International Assets Investment Management LLC increased its position in Humana by 261,025.1% during the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock worth $2,340,660,000 after purchasing an additional 738,701 shares during the last quarter. Steadfast Capital Management LP purchased a new position in Humana during the first quarter worth approximately $158,813,000. Finally, Baupost Group LLC MA acquired a new position in shares of Humana in the 2nd quarter valued at $156,933,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on HUM shares. Truist Financial lowered their price target on Humana from $400.00 to $260.00 and set a "hold" rating for the company in a research report on Friday, October 11th. Leerink Partnrs downgraded shares of Humana from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, October 2nd. Wells Fargo & Company cut their price target on shares of Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Humana from $349.00 to $250.00 and set a "hold" rating for the company in a research note on Thursday, October 3rd. Finally, Piper Sandler lowered shares of Humana from an "overweight" rating to a "neutral" rating and reduced their target price for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $315.86.
Get Our Latest Research Report on HUM
Humana Stock Performance
Shares of HUM traded up $16.24 during midday trading on Wednesday, reaching $294.02. The stock had a trading volume of 2,286,715 shares, compared to its average volume of 1,875,180. The firm has a market cap of $35.40 billion, a PE ratio of 24.62, a P/E/G ratio of 2.17 and a beta of 0.52. The firm has a 50 day simple moving average of $278.54 and a 200-day simple moving average of $331.29. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, sell-side analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.
Humana Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.20%. Humana's payout ratio is 31.36%.
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.